The Bioactive Products section contains papers on novel plant chemistry, where the biological activities of one or more of the new plant compounds are described. Descriptions of possible pharmacological, medical or therapeutic use or of dietary significance are encouraged if known. This section may also contain analysis of genetically modified plants that have been analysed for changes in their profiles of bioactive plant products. Such bioassay data should include comparable results for a known agent, so that the reader can judge the relative importance of any new finding. Full experimental details of the biological tests should be provided, and studies judgedsignificant by the Editors may be invited to be discussed in the Molecules of Interest section before publication. In such cases, this review will appear in the same issue as the publication.